Literature DB >> 2414107

High doses of gamma globulin and methylprednisolone therapy for idiopathic thrombocytopenic purpura in children.

T Hara, S Miyazaki, N Yoshida, N Goya.   

Abstract

In four children with chronic idiopathic thrombocytopenic purpura (ITP), high doses of gamma globulin or methylprednisolone were effective in increasing platelet counts transiently, yet there was no quantitative relationship between the platelet responses to these two therapies. This finding suggests a qualitative difference in the mechanisms of increasing platelets by the two drugs. High doses of gamma globulin and methylprednisolone showed a synergistic effect on the initial and maximal platelet responses, suggesting an intensification of the effect of gamma globulin by methylprednisolone. This combination therapy should be clinically useful, particularly in the control of acute haemorrhage or in preparations for emergency surgery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414107     DOI: 10.1007/bf00451950

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  High-dosage intravenously administered methylprednisolone in renal transplantation. A preliminary report.

Authors:  J E Woods; C F Anderson; J H DeWeerd; W J Johnson; J V Donadio; F J Leary; P P Frohnert
Journal:  JAMA       Date:  1973-02-19       Impact factor: 56.272

2.  Chronic thrombocytopenia in childhood.

Authors:  M E Ramos; A J Newman; S Gross
Journal:  J Pediatr       Date:  1978-04       Impact factor: 4.406

3.  Bolus methylprednisolone in severe aplastic anemia.

Authors:  A Bacigalupo; D Giordano; M T Van Lint; R Vimercati; A M Marmont
Journal:  N Engl J Med       Date:  1979-03-01       Impact factor: 91.245

4.  Increased platelet-associated IgG in child on high-dose gammaglobulin for idiopathic thrombocytopenic purpura.

Authors:  B Schmidt; J Forster
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

5.  Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

Authors:  J Fehr; V Hofmann; U Kappeler
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

6.  Bolous of methylprednisolone for aplastic anemia.

Authors:  M A Sanz; J A Martinez; J Besalduch; J Rafecas
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

Review 7.  Chronic idiopathic thrombocytopenic purpura.

Authors:  R McMillan
Journal:  N Engl J Med       Date:  1981-05-07       Impact factor: 91.245

8.  High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

Authors:  P Imbach; S Barandun; V d'Apuzzo; C Baumgartner; A Hirt; A Morell; E Rossi; M Schöni; M Vest; H P Wagner
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

9.  Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone.

Authors:  W T Butler; R D Rossen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

10.  Effect of corticosteroid therapy on the phagocytosis of antibody-coated platelets by human leukocytes.

Authors:  R I Handin; T P Stossel
Journal:  Blood       Date:  1978-05       Impact factor: 22.113

View more
  4 in total

1.  Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura.

Authors: 
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

2.  The clinical use of intravenous immunoglobulin in pediatrics.

Authors:  V Wahn
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

3.  Intravenous gamma globulin therapy for thrombocytopenic purpura associated with active varicella infection.

Authors:  T Hara; Y Mizuno; H Igarashi; K Ueda
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

Review 4.  The nontreatment of childhood idiopathic thrombocytopenic purpura.

Authors:  G R Buchanan
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.